title: Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy.
abstract: Because the number of patients requiring oral anticoagulation (OA) is steadily growing, more and more patients requiring surgical treatment of benign prostatic hyperplasia (BPH) are on OA. Laser treatment of BPH was said to offer a higher quality of hemostasis than transurethral resection of the prostate (TURP). Thus, laser was considered an interesting tool for BPH surgery in patients on OA therapy. To date, no randomized studies focusing on laser treatment in patients on OA are available. Compared to TURP, laser seems to decrease the risk of hemorrhage in patients on OA. Therefore, the laser could be considered a useful tool for managing patients on OA, and could be proposed as a first-line therapy for those patients requiring surgery. Continuing platelet aggregation inhibitors during the procedure is feasible. A switch to low molecular weight heparine medication prior to surgery is preferable to the continued use of OA during TURP. No conclusion can be reached regarding the preferred laser technique to treat these patients.
authors.affiliation: Department of Urology, CHU Limoges, 2 Avenue Martin Luther King, Limoges, 87042, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Berger
authors.forename: Gregoire
authors.initials: G
authors.lastname: Robert
authors.forename: Aurelien
authors.initials: A
authors.lastname: Descazeaud
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D006801:Humans; D053685:Laser Therapy; D008297:Male; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*
chemical_list: D000925:Anticoagulants
references.citation: Urology. 1993 Dec;42(6):738-40
references.pmid: 7504851
references.citation: Br J Urol. 1998 Apr;81(4):520-2
references.pmid: 9598620
references.citation: N Engl J Med. 1997 May 22;336(21):1506-11
references.pmid: 9154771
references.citation: J Urol. 2006 Apr;175(4):1428-32
references.pmid: 16516015
references.citation: Eur Urol. 2008 Oct;54(4):893-901
references.pmid: 18486311
references.citation: Postgrad Med J. 2008 Jan;84(987):46-9
references.pmid: 18230751
references.citation: Eur Urol. 2007 Apr;51(4):1031-8; discussion 1038-41
references.pmid: 16945475
references.citation: J Intern Med. 2005 May;257(5):399-414
references.pmid: 15836656
references.citation: Tech Urol. 1998 Sep;4(3):156-9
references.pmid: 9800899
references.citation: J Urol. 1994 Jan;151(1):79-81
references.pmid: 7504746
references.citation: Aust N Z J Surg. 1995 Jan;65(1):40-3
references.pmid: 7529490
references.citation: BJU Int. 2008 Aug;102(3):322-7
references.pmid: 18422772
references.citation: J Endourol. 2005 Dec;19(10):1199-202
references.pmid: 16359215
references.citation: J Urol. 2003 Nov;170(5):1851-5
references.pmid: 14532791
references.citation: J Endourol. 2009 Aug;23(8):1343-6
references.pmid: 19575692
references.citation: Br J Urol. 1989 Dec;64(6):623-5
references.pmid: 2627636
references.citation: J Endourol. 2005 Dec;19(10):1196-8
references.pmid: 16359214
references.citation: J Endourol. 2008 Jul;22(7):1519-25
references.pmid: 18613777
references.citation: Cochrane Database Syst Rev. 2004;(1):CD001987
references.pmid: 14973978
references.citation: Eur Urol. 2008 Jan;53(1):160-6
references.pmid: 17869409
references.citation: J Urol. 2005 Jan;173(1):158-60
references.pmid: 15592063
references.citation: J Urol. 2002 Aug;168(2):610-3; discussion 614
references.pmid: 12131319
references.citation: Eur Urol. 2006 Nov;50(5):969-79; discussion 980
references.pmid: 16469429
references.citation: BJU Int. 1999 Jun;83(9):984-9
references.pmid: 10368240
references.citation: J Urol. 1999 Oct;162(4):1307-10
references.pmid: 10492185
references.citation: Int J Urol. 2008 Dec;15(12):1067-71
references.pmid: 19054171